(Q37702771)

22 August 2017

1 reference

title

Growth and endocrine function in thalassemia major in childhood and adolescence (English)

1 reference

22 August 2017

0 references

1 reference

Delvecchio M

1

1 reference

22 August 2017

Cavallo L

series ordinal

2

1 reference

22 August 2017

language of work or name

1 reference

1 January 2010

1 reference

Journal of Endocrinological Investigation

22 August 2017

published in

1 reference

22 August 2017

volume

33

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

61-68

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03346551

22 August 2017

exact match

0 references

cites work

Stature and longitudinal growth in thalassemia major. A study of 229 Greek patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth of children with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth and puberty and its management in thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Zinc status in patients with major beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

No difference in pubertal growth and final height between treated hypogonadal and non-hypogonadal thalassemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

The impact of genotype on endocrine complications in thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Endocrinopathy in thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Endocrine complications in patients with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth hormone response following growth hormone releasing hormone injection in thalassemia major: influence of pubertal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Evaluation of hypothalamic-pituitary function in patients with thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

No evidence for a defect in growth hormone binding to liver membranes in thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth hormone secretion in polytransfused prepubertal patients with homozygous β-thalassemia. Effect of longterm recombinant GH (recGH) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Hypogonadism in beta-thalassemic adolescents: a characteristic pituitary-gonadal impairment. The ineffectiveness of long-term iron chelation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Spontaneous and GnRH-provoked gonadotropin secretion and testosterone response to human chorionic gonadotropin in adolescent boys with thalassaemia major and delayed puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Human chorionic gonadotropin therapy in adolescent boys with constitutional delayed puberty vs those with beta-thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Complications of beta-thalassemia major in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Insulin dependent diabetes in thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Disproportionately elevated fasting proinsulin levels in normoglycemic patients with thalassemia major are correlated to the degree of iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Abnormal glucose tolerance in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Diabetes mellitus in children suffering from beta-thalassaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Hormonal changes in thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Glucose intolerance in thalassemia major is related to insulin resistance and hepatic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Reduced insulin secretion in normoglycaemic patients with beta-thalassaemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Assessment of thyroid function in two hundred patients with beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Longitudinal study on thyroid function in patients with thalassemia major.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Growth Impairment in ??-Thalassemia Major: The Role of Trace Element Deficiency and Other Potential Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346551

Thyroid function in patients with homozygous beta-thalassaemia

21 January 2018

1 reference

12 December 2020

Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia

1 reference

12 December 2020

Factors determining glucose tolerance in patients with thalassemia major.

1 reference

12 December 2020

Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).

1 reference

12 December 2020

Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major

1 reference

12 December 2020

Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia

1 reference

12 December 2020

Early onset of endocrine abnormalities in beta-thalassemia major in a developing country

1 reference

12 December 2020

Growth hormone treatment in short children with beta-thalassemia major

1 reference

12 December 2020

Hypothyroidism in patients with thalassemia syndromes

1 reference

12 December 2020

Update on fertility in thalassaemia major

1 reference

12 December 2020

Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect

1 reference

12 December 2020

Growth, puberty and endocrine function in beta-thalassaemia major

1 reference

12 December 2020

Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases

1 reference

12 December 2020

Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload

1 reference

12 December 2020

Growth and management of short stature in thalassaemia major

1 reference

12 December 2020

Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia.

1 reference

12 December 2020

Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection

1 reference

12 December 2020

Evolution of glucose intolerance and diabetes in transfused patients with thalassemia

1 reference

12 December 2020

GH Secretion in Thalassemic Patients with Short Stature

1 reference

12 December 2020

Neurosecretory dysfunction of growth hormone secretion in thalassemia major

1 reference

12 December 2020

Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major

1 reference

12 December 2020

Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.

1 reference

12 December 2020

Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload

1 reference

12 December 2020

The effect of platyspondyly and pubertal growth spurt on the stature of patients with beta-thalassaemia major

1 reference

12 December 2020

Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia

1 reference

12 December 2020

GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia

1 reference

12 December 2020

Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.

1 reference

12 December 2020

Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency

1 reference

12 December 2020

Final height and body disproportion in thalassaemic boys and girls with spontaneous or induced puberty

1 reference

12 December 2020

Depressed serum somatomedin activity in beta-thalassemia

1 reference

12 December 2020

Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study

1 reference

12 December 2020

Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.

1 reference

12 December 2020

Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major

1 reference

12 December 2020

Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism

1 reference

12 December 2020

Ultrasound thyroid evaluation in thalassemic patients: correlation between the aspects of thyroidal stroma and function

1 reference

12 December 2020

[Effect of hematologic treatment on the growth and puberty of children with thalassemia major]

1 reference

12 December 2020

Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth

1 reference

12 December 2020

Endocrine Functioning in Multitransfused Prepubertal Patients with Homozygous β-Thalassemia

1 reference

12 December 2020

Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major.

1 reference

12 December 2020

Deferoxamine-induced growth retardation in patients with thalassemia major

1 reference

12 December 2020

Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy

1 reference

12 December 2020

The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with beta-thalassemia major.

1 reference

12 December 2020

Pubertal evaluation of adolescent boys with beta-thalassemia major and delayed puberty

1 reference

12 December 2020

Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test

1 reference

12 December 2020

[Growth and thalassemia]

1 reference

12 December 2020

[Growth and endocrine function in major thalassemia]

1 reference

12 December 2020

Reduced insulin growth factor I concentrations in iron-overloaded beta thalassaemic patients with normal growth hormone secretion and liver function.

1 reference

12 December 2020

Effects of zinc supplementation on linear growth in beta-thalassemia (a new approach)

1 reference

12 December 2020

Glucose disturbances and regulation with glibenclamide in thalassemia

1 reference

12 December 2020

Pituitary-thyroid function in children with beta-thalassaemia major

1 reference

12 December 2020

Endocrine function in thalassaemia

1 reference

12 December 2020

Endocrine complications in patients with Thalassaemia Major

1 reference

12 December 2020

Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening

1 reference

12 December 2020

Multiple hormone deficiencies in children with hemochromatosis.

1 reference

12 December 2020

Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test

1 reference

12 December 2020

Endocrine involvement in children with beta-thalassaemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels.

1 reference

12 December 2020

Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major

1 reference

12 December 2020

Recombinant growth hormone treatment in short patients with thalassemia major: results after 24 and 36 months

1 reference

12 December 2020

Growth and puberty in thalassemia major

1 reference

12 December 2020

Thyroid dysfunction in multi-transfused iron loaded thalassemia patients

1 reference

12 December 2020

Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease

1 reference

12 December 2020

Assessment of thyroid functions and its role in body growth in thalassemia major.

1 reference

12 December 2020

Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy

1 reference

12 December 2020

Short stature and body proportion in thalassaemia

1 reference

12 December 2020

Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major

1 reference

12 December 2020

Recombinant human growth hormone treatment in children with thalassemia major

1 reference

12 December 2020

The impact of iron overload and genotype on gonadal function in women with thalassaemia major.

1 reference

12 December 2020

Regulation of glucose disturbances with glibenclamide in patients with thalassemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346551

1 reference

22 August 2017

1 reference